podcast.de
Anmeldung
Anmeldung Registrierung
Auto Hell Dunkel
Erweiterte Suche
  1. Startseite
  2. Podcasts
  3. Medizin - Open Access LMU - Teil 17/22 Podcast
  4. Intracameral Injection of Bevacizumab for the Treatment of Neovascular Glaucoma
Purpose: To assess the duration of the effect of intracameral
bevacizumab in patients presenting with rubeosis iridis and
neovascular glaucoma (NVG). Methods: Retrospective analysis of 24
consecutive eyes of 24 patients with decompensated NVG (> 21 mm
Hg) treated with a single intracameral injection of bevacizumab
over a minimum follow-up of 6 months. The endpoint of the study was
the need for retreatment due to recurrence of raised intraocular
pressure (IOP). Secondary outcome was the course of visual acuity
(VA) and IOP over 6 months. Results: A Kaplan-Meier calculation
revealed a mean duration of the treatment effect of 23 +/- 4.4
days. Compared to mean IOP before treatment (26.3 mm Hg), decreases
to 17.5 mm Hg at 1 week after treatment (p < 0.002) and to 17.1
mm Hg (p < 0.005) at 6 months following a single injection were
seen. At 6 months, additional treatment was performed in 87.5% (n =
21) of eyes. VA remained stable or improved in 75% (n = 18) of all
cases. Conclusion: The IOP-lowering effect of intracameral
bevacizumab can be seen 1 week after the injection, but is limited
to a period of approximately 3 weeks. However, the fast and
effective response to intracameral bevacizumab injection opens a
time window for additional treatments, which are often necessary.
Copyright (C) 2011 S. Karger AG, Basel

Weitere Episoden

Analysis of IL2/IL21 Gene Variants in Cholestatic Liver Diseases Reveals an Association with Primary Sclerosing Cholangitis

Analysis of IL2/IL21 Gene Variants in Cholestatic Liver Diseases Reveals an Association with Primary Sclerosing Cholangitis

vor 15 Jahren
Biliary Bicarbonate Secretion Constitutes a Protective Mechanism against Bile Acid-Induced Injury in Man

Biliary Bicarbonate Secretion Constitutes a Protective Mechanism against Bile Acid-Induced Injury in Man

vor 15 Jahren
Growth Pattern of Untreated Boys with Simple Virilizing Congenital Adrenal Hyperplasia Indicates Relative Androgen Insensitivity during the First Six Months of Life

Growth Pattern of Untreated Boys with Simple Virilizing Congenital Adrenal Hyperplasia Indicates Relative Androgen Insensitivity during the First Six Months of Life

vor 15 Jahren
Growth Patterns in the First Three Years of Life in Children with Classical Congenital Adrenal Hyperplasia Diagnosed by Newborn Screening and Treated with Low Doses of Hydrocortisone

Growth Patterns in the First Three Years of Life in Children with Classical Congenital Adrenal Hyperplasia Diagnosed by Newborn Screening and Treated with Low Doses of Hydrocortisone

vor 15 Jahren
Missing Heritability in the Tails of Quantitative Traits? A Simulation Study on the Impact of Slightly Altered True Genetic Models

Missing Heritability in the Tails of Quantitative Traits? A Simulation Study on the Impact of Slightly Altered True Genetic Models

vor 15 Jahren
Alle Episoden anzeigen
In Podcasts werben
Schalte jetzt Werbung in Podcasts.
Episode melden

„Intracameral Injection of Bevacizumab for the Treatment of Neovascular Glaucoma“

Worum geht es? Danach fragen wir noch nach dem Grund.

Abonnenten

Er
Erasmus2

Teilen

Mein Archiv

Deine Privatkopie der Folgen, die du nicht verlieren willst.

Podcast-Folgen verschwinden. Feeds werden auf die letzten Episoden gekürzt, Hoster räumen alte Dateien ab, Formate wechseln den Anbieter und lassen ihr Archiv zurück. Mit „Mein Archiv“ sichert podcast.de die Folgen deiner Podcasts für dich — angefangen bei den ältesten, denn die sind zuerst weg.

  • Deine gesicherten Folgen bleiben hörbar, auch wenn das Original offline geht.
  • Auch Folgen, die im heutigen Feed gar nicht mehr stehen — podcast.de kennt sie noch.
  • Herunterladen bleibt möglich, solange die Folge beim Podcaster liegt. Der zählt seine Abrufe wie bisher.
Startet bald

Sei beim Start von Mein Archiv dabei

Mein Archiv ist fast fertig. Trag dich ein, dann bekommst du eine E-Mail, sobald es losgeht – und bist von Anfang an dabei. Wir schreiben dir nur zum Start, keine Werbung, keine Weitergabe deiner Daten.

Du bekommst zuerst eine Bestätigungsmail. Abmelden geht jederzeit. Datenschutz